Skip to main content

Table 4 Cardiovascular risk assessments of smokers, CV ASPIRE study, Europe, 2011

From: Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: Results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) Study

Cardiovascular risk

Risk score

n

Smokers (a) (N=1439)

Hypothetical non-smokers (b) (N=1439)

Risk difference (a-b)

Risk ratio (a-b/b)

10-year Cardiovascular Mortality Risk, mean % (range)

SCORE

1419

4.0% (0%-26%)

2.0% (0%-14%)

2.0%

100%

10-year Coronary Heart Disease Risk, mean % (range)

Framingham

1275

17.9% (1%-84%)

11.9% (1%-66%)

6.0%

50%

10-Year Cardiovascular Disease Risk, mean % (range)

Framingham

1368

21.2% (2%-30%)

16.0% (1%-30%)

5.1%

32%

10-Year Hard Coronary Heart Disease Risk, mean % (range)

Framingham

1372

13.2% (0%-49%)

8.0% (0%-48%)

5.2%

65%

4-Year Intermittent Claudication Risk, mean % (range)

Framingham

1161

2.8% (0%-36%)

1.5% (0%-20%)

1.3%

87%

2-Year Recurring Coronary Heart Disease Risk (amongst females with history of CHD), mean % (range)

Framingham

68

6.4% (2%-21%)

4.5% (1%-15%)

1.8%

40%

10-Year Risk (%) of Coronary or Cardiovascular Event, mean % (range)

Progetto CUORE

1117

10.3% (0%-77%)

6.2% (0%-58%)

4.2%

68%